Which has higher valuation and earnings, SDGR or PHR?

Phreesia has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 5.68 -$103.26M -$0.74 N/A Phreesia $480.59M 1.57 $2.31M $0.15 81.13

Is SDGR or PHR more profitable?

Phreesia has a net margin of 1.85% compared to Schrodinger's net margin of -20.98%. Phreesia's return on equity of 5.13% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Phreesia 1.85% 5.13% 3.12%

Does the media refer more to SDGR or PHR?

In the previous week, Schrodinger had 1 more articles in the media than Phreesia. MarketBeat recorded 9 mentions for Schrodinger and 8 mentions for Phreesia. Phreesia's average media sentiment score of 1.24 beat Schrodinger's score of 1.23 indicating that Phreesia is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Phreesia 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, PHR or CERT?

Phreesia has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phreesia $480.59M 1.57 $2.31M $0.15 81.13 Certara $418.84M 3.04 -$1.60M -$0.45 N/A

Is PHR or CERT more profitable?

Phreesia has a net margin of 1.85% compared to Certara's net margin of -16.75%. Phreesia's return on equity of 5.13% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Phreesia 1.85% 5.13% 3.12% Certara -16.75% 3.86% 2.65%

Does the media refer more to PHR or CERT?

In the previous week, Phreesia had 4 more articles in the media than Certara. MarketBeat recorded 8 mentions for Phreesia and 4 mentions for Certara. Certara's average media sentiment score of 1.78 beat Phreesia's score of 1.24 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Certara 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger valuation and earnings, PHR or GDRX?

GoodRx has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phreesia $480.59M 1.57 $2.31M $0.15 81.13 GoodRx $796.85M 1.52 $30.44M $0.04 88.25

Is PHR or GDRX more profitable?

GoodRx has a net margin of 2.07% compared to Phreesia's net margin of 1.85%. GoodRx's return on equity of 7.22% beat Phreesia's return on equity. Company Net Margins Return on Equity Return on Assets Phreesia 1.85% 5.13% 3.12% GoodRx 2.07% 7.22% 2.53%

Does the media refer more to PHR or GDRX?

In the previous week, GoodRx had 2 more articles in the media than Phreesia. MarketBeat recorded 10 mentions for GoodRx and 8 mentions for Phreesia. Phreesia's average media sentiment score of 1.24 beat GoodRx's score of 0.31 indicating that Phreesia is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PHR or TDOC?

In the previous week, Teladoc Health had 6 more articles in the media than Phreesia. MarketBeat recorded 14 mentions for Teladoc Health and 8 mentions for Phreesia. Phreesia's average media sentiment score of 1.24 beat Teladoc Health's score of 0.67 indicating that Phreesia is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teladoc Health 8 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has stronger earnings & valuation, PHR or HSTM?

HealthStream has lower revenue, but higher earnings than Phreesia. HealthStream is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phreesia $480.59M 1.57 $2.31M $0.15 81.13 HealthStream $321.12M 2.67 $18.34M $0.72 40.81

Does the media prefer PHR or HSTM?

In the previous week, Phreesia had 3 more articles in the media than HealthStream. MarketBeat recorded 8 mentions for Phreesia and 5 mentions for HealthStream. Phreesia's average media sentiment score of 1.24 beat HealthStream's score of 0.97 indicating that Phreesia is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthStream 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Phreesia (PHR) Competitors

$12.17 +0.02 (+0.16%)

As of 08/28/2026 03:58 PM Eastern

Compare

PHR vs. SDGR, CERT, GDRX, TDOC, and HSTM

Should you buy Phreesia stock or one of its competitors? Phreesia's main competitors and comparable companies include Schrodinger (SDGR), Certara (CERT), GoodRx (GDRX), Teladoc Health (TDOC), and HealthStream (HSTM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Phreesia compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Phreesia (NYSE:PHR) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

Phreesia has a net margin of 1.85% compared to Schrodinger's net margin of -20.98%. Phreesia's return on equity of 5.13% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Phreesia	1.85%	5.13%	3.12%

79.1% of Schrodinger shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 10.1% of Schrodinger shares are held by company insiders. Comparatively, 5.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Schrodinger has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market. Comparatively, Phreesia has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market.

Phreesia has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	5.68	-$103.26M	-$0.74	N/A
Phreesia	$480.59M	1.57	$2.31M	$0.15	81.13

In the previous week, Schrodinger had 1 more articles in the media than Phreesia. MarketBeat recorded 9 mentions for Schrodinger and 8 mentions for Phreesia. Phreesia's average media sentiment score of 1.24 beat Schrodinger's score of 1.23 indicating that Phreesia is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Phreesia	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Schrodinger presently has a consensus target price of $20.50, indicating a potential upside of 4.06%. Phreesia has a consensus target price of $16.65, indicating a potential upside of 36.79%. Given Phreesia's stronger consensus rating and higher possible upside, analysts plainly believe Phreesia is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42

Summary

Phreesia beats Schrodinger on 12 of the 16 factors compared between the two stocks.

How does Phreesia compare to Certara?

Phreesia (NYSE:PHR) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 5.2% of Phreesia shares are owned by company insiders. Comparatively, 1.1% of Certara shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Phreesia has a net margin of 1.85% compared to Certara's net margin of -16.75%. Phreesia's return on equity of 5.13% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
Certara	-16.75%	3.86%	2.65%

In the previous week, Phreesia had 4 more articles in the media than Certara. MarketBeat recorded 8 mentions for Phreesia and 4 mentions for Certara. Certara's average media sentiment score of 1.78 beat Phreesia's score of 1.24 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Certara	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Phreesia has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Certara has a beta of 1.44, suggesting that its stock price is 44% more volatile than the broader market.

Phreesia presently has a consensus target price of $16.65, indicating a potential upside of 36.79%. Certara has a consensus target price of $8.28, indicating a potential downside of 0.86%. Given Phreesia's stronger consensus rating and higher possible upside, equities analysts plainly believe Phreesia is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Phreesia has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.57	$2.31M	$0.15	81.13
Certara	$418.84M	3.04	-$1.60M	-$0.45	N/A

Summary

Phreesia beats Certara on 13 of the 17 factors compared between the two stocks.

How does Phreesia compare to GoodRx?

Phreesia (NYSE:PHR) and GoodRx (NASDAQ:GDRX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

In the previous week, GoodRx had 2 more articles in the media than Phreesia. MarketBeat recorded 10 mentions for GoodRx and 8 mentions for Phreesia. Phreesia's average media sentiment score of 1.24 beat GoodRx's score of 0.31 indicating that Phreesia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Phreesia has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market. Comparatively, GoodRx has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

GoodRx has a net margin of 2.07% compared to Phreesia's net margin of 1.85%. GoodRx's return on equity of 7.22% beat Phreesia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
GoodRx	2.07%	7.22%	2.53%

GoodRx has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.57	$2.31M	$0.15	81.13
GoodRx	$796.85M	1.52	$30.44M	$0.04	88.25

92.1% of Phreesia shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 5.2% of Phreesia shares are held by company insiders. Comparatively, 5.9% of GoodRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Phreesia currently has a consensus price target of $16.65, suggesting a potential upside of 36.79%. GoodRx has a consensus price target of $4.23, suggesting a potential upside of 19.75%. Given Phreesia's stronger consensus rating and higher possible upside, equities research analysts plainly believe Phreesia is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

Summary

Phreesia and GoodRx tied by winning 8 of the 16 factors compared between the two stocks.

How does Phreesia compare to Teladoc Health?

Phreesia (NYSE:PHR) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

92.1% of Phreesia shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 5.2% of Phreesia shares are held by insiders. Comparatively, 0.7% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Phreesia has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, meaning that its share price is 112% more volatile than the broader market.

Phreesia has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.57	$2.31M	$0.15	81.13
Teladoc Health	$2.53B	0.47	-$200.32M	-$0.99	N/A

In the previous week, Teladoc Health had 6 more articles in the media than Phreesia. MarketBeat recorded 14 mentions for Teladoc Health and 8 mentions for Phreesia. Phreesia's average media sentiment score of 1.24 beat Teladoc Health's score of 0.67 indicating that Phreesia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	8 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Phreesia has a net margin of 1.85% compared to Teladoc Health's net margin of -7.13%. Phreesia's return on equity of 5.13% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
Teladoc Health	-7.13%	-12.15%	-5.83%

Phreesia presently has a consensus price target of $16.65, suggesting a potential upside of 36.79%. Teladoc Health has a consensus price target of $7.54, suggesting a potential upside of 15.76%. Given Phreesia's stronger consensus rating and higher probable upside, analysts plainly believe Phreesia is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Phreesia beats Teladoc Health on 13 of the 16 factors compared between the two stocks.

How does Phreesia compare to HealthStream?

Phreesia (NYSE:PHR) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Phreesia had 3 more articles in the media than HealthStream. MarketBeat recorded 8 mentions for Phreesia and 5 mentions for HealthStream. Phreesia's average media sentiment score of 1.24 beat HealthStream's score of 0.97 indicating that Phreesia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Phreesia has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, HealthStream has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

HealthStream has a net margin of 6.60% compared to Phreesia's net margin of 1.85%. HealthStream's return on equity of 6.81% beat Phreesia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
HealthStream	6.60%	6.81%	4.64%

HealthStream has lower revenue, but higher earnings than Phreesia. HealthStream is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.57	$2.31M	$0.15	81.13
HealthStream	$321.12M	2.67	$18.34M	$0.72	40.81

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 5.2% of Phreesia shares are owned by company insiders. Comparatively, 20.4% of HealthStream shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Phreesia currently has a consensus target price of $16.65, indicating a potential upside of 36.79%. HealthStream has a consensus target price of $27.00, indicating a potential downside of 8.10%. Given Phreesia's stronger consensus rating and higher possible upside, equities analysts plainly believe Phreesia is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Phreesia beats HealthStream on 9 of the 16 factors compared between the two stocks.

Get Phreesia News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PHR vs. The Competition

Export

Metric	Phreesia	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$752.23M	$1.80B	$7.18B	$24.12B
Dividend Yield	N/A	4.69%	2.54%	3.72%
P/E Ratio	81.13	21.94	273.17	30.01
Price / Sales	1.57	86.81	638.19	23.54
Price / Cash	16.28	31.93	28.74	19.75
Price / Book	2.18	6.31	11.08	4.84
Net Income	$2.31M	-$18.66M	$3.48B	$1.07B
7 Day Performance	3.92%	2.82%	0.38%	-0.41%
1 Month Performance	13.46%	15.30%	7.89%	2.04%
1 Year Performance	-61.57%	-14.96%	24.71%	13.37%

Phreesia Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PHR Phreesia	4.2439 of 5 stars	$12.17 +0.2%	$16.65 +36.8%	-61.6%	$752.23M	$480.59M	81.13	1,789	Positive News Upcoming Earnings Gap Down
SDGR Schrodinger	1.3002 of 5 stars	$18.77 -4.8%	$20.50 +9.2%	+1.0%	$1.46B	$255.87M	N/A	790
CERT Certara	1.8211 of 5 stars	$7.96 -5.6%	$8.28 +4.0%	-23.0%	$1.29B	$418.84M	N/A	1,576	Positive News
GDRX GoodRx	4.3537 of 5 stars	$3.44 -0.3%	$4.23 +22.9%	-18.9%	$1.18B	$796.85M	86.02	950
TDOC Teladoc Health	2.9173 of 5 stars	$6.20 -3.1%	$7.54 +21.6%	-15.9%	$1.16B	$2.53B	N/A	5,600

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PHR) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Phreesia (PHR) Competitors

PHR vs. SDGR, CERT, GDRX, TDOC, and HSTM

How does Phreesia compare to Schrodinger?

Summary

How does Phreesia compare to Certara?

Summary

How does Phreesia compare to GoodRx?

Summary

How does Phreesia compare to Teladoc Health?

Summary

How does Phreesia compare to HealthStream?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHR vs. The Competition

Phreesia Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Phreesia (PHR) Competitors

PHR vs. SDGR, CERT, GDRX, TDOC, and HSTM

How does Phreesia compare to Schrodinger?

Is SDGR or PHR more profitable?

Do institutionals & insiders have more ownership in SDGR or PHR?

Which has more volatility & risk, SDGR or PHR?

Which has higher valuation and earnings, SDGR or PHR?

Does the media refer more to SDGR or PHR?

Do analysts recommend SDGR or PHR?

Summary

How does Phreesia compare to Certara?

Do institutionals and insiders believe in PHR or CERT?

Is PHR or CERT more profitable?

Does the media refer more to PHR or CERT?

Which has more volatility & risk, PHR or CERT?

Do analysts prefer PHR or CERT?

Which has higher earnings & valuation, PHR or CERT?

Summary

How does Phreesia compare to GoodRx?

Does the media refer more to PHR or GDRX?

Which has more volatility and risk, PHR or GDRX?

Is PHR or GDRX more profitable?

Which has stronger valuation and earnings, PHR or GDRX?

Do institutionals and insiders hold more shares of PHR or GDRX?

Do analysts recommend PHR or GDRX?

Summary

How does Phreesia compare to Teladoc Health?

Do institutionals and insiders hold more shares of PHR or TDOC?

Which has more risk and volatility, PHR or TDOC?

Which has higher valuation & earnings, PHR or TDOC?

Does the media prefer PHR or TDOC?

Is PHR or TDOC more profitable?

Do analysts prefer PHR or TDOC?

Summary

How does Phreesia compare to HealthStream?

Does the media prefer PHR or HSTM?

Which has more volatility and risk, PHR or HSTM?

Is PHR or HSTM more profitable?

Which has stronger earnings & valuation, PHR or HSTM?

Do institutionals and insiders believe in PHR or HSTM?

Do analysts recommend PHR or HSTM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHR vs. The Competition

Phreesia Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools